Nothing new in this, another segment, another survey and India has been chosen as the future hotspot. According to a study done by consulting firm AT Kearney India will become no.2 destination for clinical trial outsourcing. I am sure you know as usual the first position is held by China. Russia is close third.
AT Kearney has conducted the study in 15 countries and looked at variables like patient availability, cost efficiency, relevant expertise, regulatory conditions and national infrastructure availability among other things.
India may have scored with large patient pool, faster enrollment and low cost but it also losses points on factors like lack of infrastructure and a strong hospital network.
Comment Preview